Comparison of Prevena Negative Pressure Incision Management System vs. Standard Dressing After Va… (NCT02389023) | Clinical Trial Compass
UnknownNot Applicable
Comparison of Prevena Negative Pressure Incision Management System vs. Standard Dressing After Vascular Surgery
United States242 participantsStarted 2015-09
Plain-language summary
The purpose of this study is to evaluate the effectiveness of negative pressure incision management system (Prevena™ Incision Management System (PIMS) or ActiVAC® with the Prevena™ Dressings (Peel and Place™ or Customizable™), KCI) in the prevention of wound complications including surgical site infection (SSI) and non-infectious complications in patients undergoing vascular surgery with groin incisions.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age ≥ 18
✓. Patient undergoing vascular surgery that would include a groin incision as a standard part of the operation. Infrainguinal bypass including femoral popliteal/tibial/pedal artery bypass with autogenous or prosthetic conduit.
✓. femoral endarterectomy with or without patch angioplasty involving the common femoral artery and/or profunda and/or proximal superficial artery. The index groin may have undergone prior procedures (may be inflow or outflow for existing grafts), but the patient must have fully healed from the prior operation. May include patients with concomitant proximal and/or distal peripheral vascular intervention. The patch may be autogenous venous or arterial or prosthetic material such as bovine pericardium, dacron or polytetrafluoroethylene (PTFE). Bilateral femoral endarterectomies are eligible for enrollment. The right and left groin incision would be randomized to the same dressing which is consistent with routine clinical practice.
✓. Willing to comply with protocol, attend follow-up appointments, complete all study assessments, and provide written informed consent.
Exclusion criteria
✕. Any groin incision on index leg within 12 weeks prior to treatment initiation.
✕. Infrainguinal bypass without a groin incision including popliteal-tibial or pedal bypass.
✕. Supra inguinal procedures such as open or endovascular abdominal aortic aneurysm repair or aorto-femoral/bi-femoral bypass for occlusive disease.
✕. Undergoing current chemotherapy or radiation therapy.
✕
What they're measuring
1
The primary outcome measure will be a composite endpoint of surgical site infection as per Center for Disease Control definition, major wound non-infectious complications, or graft infection within 30 days of surgery.
✕. Inability or refusal to provide informed consent.
✕. Patients who received an investigational drug for peripheral arterial disease within 4 weeks of screening or who participated in another non-observational clinical trial in the prior 30 days.
✕. Surgical incision in the groin without primary closure including previously open or infected wounds.